Old drug, new hope? ivermectin tackles stubborn skin disease

This early study tested whether the drug ivermectin could safely treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can appear after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL took ivermectin pills for five days each month for three months. Researchers monitored for side effects and checked if skin lesions improved. The goal was to see if ivermectin could offer a simpler, shorter treatment option.